Christer de Flon
Algemeen Directeur bij Blå Stjärnans Djursjukhus Forvaltnings AB
Profiel
Mr. Christer de Flon is Global Head-Marketing & Sales at Xvivo Perfusion AB and Chief Executive Officer at Blå Stjärnans Djursjukhus Forvaltnings AB.
Mr. de Flon was previously employed as Chief Executive Officer by A.
Carlsson Research AB, a Principal by Astra Hässle AB, a Principal by AstraZeneca AB, and Executive Vice President by Vitrolife AB.
He also served on the board at Ortoma AB.
He received his graduate degree from the University of Gothenburg.
Actieve functies van Christer de Flon
| Bedrijven | Functie | Begin |
|---|---|---|
Blå Stjärnans Djursjukhus Forvaltnings AB
 Blå Stjärnans Djursjukhus Forvaltnings AB Agricultural Commodities/MillingProcess Industries Part of Stift Svenska Blå Stjärnans Djursjukh i Gbg, Blå Stjärnans Djursjukhus Forvaltnings AB is a veterinary services company based in Gothenburg, Sweden. The Swedish company provides veterinary services. The CEO of the company is Christer de Flon. | Algemeen Directeur | 31-05-2010 |
Eerdere bekende functies van Christer de Flon
| Bedrijven | Functie | Einde |
|---|---|---|
| XVIVO PERFUSION AB | Verkoop & Marketing | - |
AstraZeneca AB
 AstraZeneca AB Miscellaneous Commercial ServicesCommercial Services AstraZeneca AB engages in biopharmaceutical business. It provides treatment of diseases in cardiovascular and metabolic diseases, cancer, respiratory, inflammation, and autoimmunity. The firm offers operations in the areas of infection, neuroscience, and stomach and intestinal diseases. The company was founded in 1999 and is headquartered in Sodertalje, Sweden. | Corporate Officer/Principal | - |
| Astra Hässle AB | Corporate Officer/Principal | - |
| VITROLIFE AB | Corporate Officer/Principal | - |
A. Carlsson Research AB
 A. Carlsson Research AB Pharmaceuticals: MajorHealth Technology Part of NTG Nordic Transport Group A/S, A. Carlsson Research AB develops and discovers new pharmacological treatment principles for psychiatric and neurological disorders. The company is based in Gothenburg, Sweden. The CEO of the Swedish company is Arvid M. Carlsson. A. Carlsson Research was acquired by NTG Nordic Transport Group A/S on October 23, 2006 for $121.91 million. | President | - |
Opleiding van Christer de Flon
| University of Gothenburg | Graduate Degree |
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
| Beursgenoteerde bedrijven | 3 |
|---|---|
| VITROLIFE AB | Health Technology |
| ORTOMA AB | Health Services |
| XVIVO PERFUSION AB | Health Technology |
| Bedrijven in privébezit | 4 |
|---|---|
AstraZeneca AB
AstraZeneca AB Miscellaneous Commercial ServicesCommercial Services AstraZeneca AB engages in biopharmaceutical business. It provides treatment of diseases in cardiovascular and metabolic diseases, cancer, respiratory, inflammation, and autoimmunity. The firm offers operations in the areas of infection, neuroscience, and stomach and intestinal diseases. The company was founded in 1999 and is headquartered in Sodertalje, Sweden. | Commercial Services |
A. Carlsson Research AB
A. Carlsson Research AB Pharmaceuticals: MajorHealth Technology Part of NTG Nordic Transport Group A/S, A. Carlsson Research AB develops and discovers new pharmacological treatment principles for psychiatric and neurological disorders. The company is based in Gothenburg, Sweden. The CEO of the Swedish company is Arvid M. Carlsson. A. Carlsson Research was acquired by NTG Nordic Transport Group A/S on October 23, 2006 for $121.91 million. | Health Technology |
| Astra Hässle AB | |
Blå Stjärnans Djursjukhus Forvaltnings AB
Blå Stjärnans Djursjukhus Forvaltnings AB Agricultural Commodities/MillingProcess Industries Part of Stift Svenska Blå Stjärnans Djursjukh i Gbg, Blå Stjärnans Djursjukhus Forvaltnings AB is a veterinary services company based in Gothenburg, Sweden. The Swedish company provides veterinary services. The CEO of the company is Christer de Flon. | Process Industries |
